Friday 23rd October 2020 Missed our free GatewayC webinar on Acute Leukaemia? Watch our recording here. In this webinar GatewayC met Dr Amit Patel, a Consultant in Cellular Therapies and Stem Cell Transplantation, who answered key questions from our audience. These...
Potential pitfall: In the early course of the disease, pancreatic cancer may not cause any signs or symptoms. However, sudden onset diabetes in groups of patients for whom this would be unexpected can be an early indicator. Helpful hint: NICE NG12 guidelines recommend...
Potential pitfall: In the early course of the disease, pancreatic cancer may not cause any signs or symptoms. However, sudden onset diabetes in groups of patients for whom this would be unexpected can be an early indicator. Helpful hint: NICE NG12 guidelines recommend...
Potential pitfall: Jaundice can be a classic symptom of pancreatic cancer; about half of patients have jaundice when they first go to their GP. Yet, pancreatic cancer is difficult to diagnose as symptoms can vary or may be late, vague and non-specific. Helpful hint:...
Potential pitfall:
A negative bowel screening test should not be used to make decisions about referral in a symptomatic patient. Sensitivity levels have been set very differently for screening and symptomatic Faecal Immunochemical Tests (FIT).
Helpful hint:
The screening sensitivity threshold is 120ug/g in England (150ug/g in Wales and 80ug/g in Scotland). In symptomatic patients, the NICE DG30 guidance recommends that results should be reported using a threshold of 10 micrograms of haemoglobin per gram of faeces.
Cancer Keys are brought to you by GatewayC.
Download this Cancer Key here
Read the NICE NG12 guidance here
Access GatewayC’s Faecal Immunochemical Test (FIT) course here